Bios Health Group’s Post

The recent Fed rate cut makes now the ideal time for Biotech and Life Science companies to consider Venture Debt Capital. With our Venture Debt Capital Program, you can secure fast capital while maintaining full control of your business. Don’t let capital interruptions slow your progress. Apply today to determine eligibility: https://lnkd.in/ghTZYqHU  #VentureDebt #GrowthCapital #Biotech #LifeSciences

  • No alternative text description for this image

With the recent Fed Rate cut this is ab excellent option for Biotech and Life Science companies that need access capital quickly without equity dilution.

Like
Reply

To view or add a comment, sign in

Explore topics